NCT02335827View on ClinicalTrials.gov

Irreversible Electroporation(IRE) For Unresectable Renal Tumors

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

May 20, 2020

Study Completion Date

January 1, 2021

Conditions
Renal Tumor
Interventions
PROCEDURE

irreversible electroporation

Percutaneous (CT-guided and/or US-guided) or open IRE with voltage in level B for renal tumors

Trial Locations (1)

510665

Fuda Cancer Hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02335827 - Irreversible Electroporation(IRE) For Unresectable Renal Tumors | Biotech Hunter | Biotech Hunter